Literature DB >> 11050418

Leukocytes navigate by compass: roles of PI3Kgamma and its lipid products.

P Rickert1, O D Weiner, F Wang, H R Bourne, G Servant.   

Abstract

Morphologic polarity is necessary for the motility of mammalian cells. In leukocytes responding to a chemoattractant, this polarity is regulated by activities of small Rho guanosine triphosphatases (Rho GTPases) and the phosphoinositide 3-kinases (PI3Ks). Moreover, in neutrophils, lipid products of PI3Ks appear to regulate activation of Rho GTPases, are required for cell motility and accumulate asymmetrically to the plasma membrane at the leading edge of polarized cells. By spatially regulating Rho GTPases and organizing the leading edge of the cell, PI3Ks and their lipid products could play pivotal roles not only in establishing leukocyte polarity but also as compass molecules that tell the cell where to crawl.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11050418      PMCID: PMC2819116          DOI: 10.1016/s0962-8924(00)01841-9

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  56 in total

1.  Akt/PKB localisation and 3' phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction.

Authors:  S J Watton; J Downward
Journal:  Curr Biol       Date:  1999-04-22       Impact factor: 10.834

Review 2.  Structure and function of phosphoinositide 3-kinases.

Authors:  M P Wymann; L Pirola
Journal:  Biochim Biophys Acta       Date:  1998-12-08

3.  A tyrosine kinase signaling pathway accounts for the majority of phosphatidylinositol 3,4,5-trisphosphate formation in chemoattractant-stimulated human neutrophils.

Authors:  A Ptasznik; E R Prossnitz; D Yoshikawa; A Smrcka; A E Traynor-Kaplan; G M Bokoch
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

4.  Nonreceptor Protein-Tyrosine Kinases in Neutrophil Activation

Authors: 
Journal:  Methods       Date:  1996-06       Impact factor: 3.608

5.  Roles of non-catalytic subunits in gbetagamma-induced activation of class I phosphoinositide 3-kinase isoforms beta and gamma.

Authors:  U Maier; A Babich; B Nürnberg
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

6.  Inhibition of monocyte chemotaxis to C-C chemokines by antisense oligonucleotide for cytosolic phospholipase A2.

Authors:  M Locati; G Lamorte; W Luini; M Introna; S Bernasconi; A Mantovani; S Sozzani
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

7.  The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils.

Authors:  V Niggli; H Keller
Journal:  Eur J Pharmacol       Date:  1997-09-17       Impact factor: 4.432

8.  Rho family GTPases bind to phosphoinositide kinases.

Authors:  K F Tolias; L C Cantley; C L Carpenter
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

9.  Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases.

Authors:  J Liliental; S Y Moon; R Lesche; R Mamillapalli; D Li; Y Zheng; H Sun; H Wu
Journal:  Curr Biol       Date:  2000-04-06       Impact factor: 10.834

10.  The role of Far1p in linking the heterotrimeric G protein to polarity establishment proteins during yeast mating.

Authors:  A C Butty; P M Pryciak; L S Huang; I Herskowitz; M Peter
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

View more
  88 in total

1.  An SH2-domain-containing kinase negatively regulates the phosphatidylinositol-3 kinase pathway.

Authors:  J Moniakis; S Funamoto; M Fukuzawa; J Meisenhelder; T Araki; T Abe; R Meili; T Hunter; J Williams; R A Firtel
Journal:  Genes Dev       Date:  2001-03-15       Impact factor: 11.361

2.  Models of eukaryotic gradient sensing: application to chemotaxis of amoebae and neutrophils.

Authors:  Andre Levchenko; Pablo A Iglesias
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

Review 3.  Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases.

Authors:  Adam P Curnock; Marisa K Logan; Stephen G Ward
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

4.  Functional differences between human formyl peptide receptor isoforms 26, 98, and G6.

Authors:  Katharina Wenzel-Seifert; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-05       Impact factor: 3.000

5.  Receptor-mediated regulation of PI3Ks confines PI(3,4,5)P3 to the leading edge of chemotaxing cells.

Authors:  Yi Elaine Huang; Miho Iijima; Carole A Parent; Satoru Funamoto; Richard A Firtel; Peter Devreotes
Journal:  Mol Biol Cell       Date:  2003-02-06       Impact factor: 4.138

Review 6.  Signaling pathways at the leading edge of chemotaxing cells.

Authors:  Chang Y Chung; Richard A Firtel
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

7.  SWAP-70 identifies a transitional subset of actin filaments in motile cells.

Authors:  Pirta Hilpelä; Pia Oberbanscheidt; Penelope Hahne; Martin Hund; Georg Kalhammer; J Victor Small; Martin Bähler
Journal:  Mol Biol Cell       Date:  2003-04-17       Impact factor: 4.138

8.  Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice.

Authors:  Annalisa Del Prete; William Vermi; Erica Dander; Karel Otero; Laura Barberis; Walter Luini; Sergio Bernasconi; Marina Sironi; Amerigo Santoro; Cecilia Garlanda; Fabio Facchetti; Matthias P Wymann; Annunciata Vecchi; Emilio Hirsch; Alberto Mantovani; Silvano Sozzani
Journal:  EMBO J       Date:  2004-08-19       Impact factor: 11.598

Review 9.  Understanding eukaryotic chemotaxis: a pseudopod-centred view.

Authors:  Robert H Insall
Journal:  Nat Rev Mol Cell Biol       Date:  2010-05-06       Impact factor: 94.444

10.  Two phases of actin polymerization display different dependencies on PI(3,4,5)P3 accumulation and have unique roles during chemotaxis.

Authors:  Lingfeng Chen; Chris Janetopoulos; Yi Elaine Huang; Miho Iijima; Jane Borleis; Peter N Devreotes
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.